Author: University of Liverpool
Source: Medical Xpress
Publish date: August 6, 2025
Lasting consequences of socioeconomic disadvantage on child mental health
Socioeconomic inequalities in children’s mental health are already evident by age 5 and persist throughout childhood and adolescence, according to an analysis led by researchers from the University of Liverpool.
The study provides one of the most comprehensive examinations to date of how different types of mental health difficulties—internalising (e.g., anxiety, sadness) and externalising (e.g., impulsivity, defiance)—manifest across childhood and adolescence, and how these patterns are shaped by early life socioeconomic disadvantage.
Researchers analysed data from more than 15,000 children born about the year 2000 and tracked through to age 17, using parent-reported measures. The team, including academics from the University of Liverpool and the University of Glasgow, found that while different types of mental health difficulties vary by age and sex, the gap between more and less advantaged children remains strikingly stable across time.
Dr. Yu Wei Chua, lead author and Research Associate in the Health Inequalities and Policy Research Group at the University of Liverpool, and NIHR Researcher at the Oxford Health Biomedical Research Consortium said, “Our findings show that the mental health gap is already firmly in place by age 5, regardless of whether we use income or maternal education to index socioeconomic disadvantage.” The results are published in the journal Social Science & Medicine.
Key findings include:
- Externalising difficulties (e.g., behavioral problems) remained fairly stable over time, with boys showing higher levels than girls.
- Internalising difficulties (e.g., anxiety and depression) increased with age, particularly among adolescent girls.
- Socioeconomic inequalities were present across all ages and both sexes, with larger gaps observed in externalising difficulties.
- These inequalities did not significantly change between ages 5 and 17, highlighting the enduring influence of early-life disadvantage.
Although developmental patterns and sex differences in mental health were evident, the persistence of inequality suggests that efforts to address disparities need to begin in the early years and continue throughout the school-age period.
Dr. Yu Wei Chua states, “This research confirms that we cannot wait until problems arise in adolescence to intervene. Mental health inequalities are already entrenched in early childhood. But there is another window of opportunity in adolescence, especially to prevent a further rise in internalising difficulties in adolescents facing disadvantage.”
The study authors call for a multifaceted, multi-system approach to reduce inequalities, including:
- Early interventions through investment in early childhood education and care, to better detect and support children showing early signs of difficulty.
- School-based mental health support during adolescence, particularly to address the rise in internalising difficulties among girls.
- Addressing wider social determinants, including child poverty, parental mental health, and parenting support.
Dr. Anna Pearce, Senior Research Fellow (Public Health) at the University of Glasgow and the paper’s co-author concludes, “Reducing child poverty remains fundamental, but it’s equally critical to support families and children across multiple systems—health, education, and social care.”
“Now, we need more research on poverty reduction strategies and the role that families, services and communities play in tackling mental health inequalities.”
More information
This article was from Medical Xpress and was licensed to Novartis for Novartis’ use by the Industry Dive Content Marketplace. Please direct all licensing questions to [email protected].
Related content
UK | April 2026 | FA-11628072
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.